NCT00602173View on ClinicalTrials.gov

Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Intermittent Claudication
Interventions
DRUG

Cilostazol

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602173 - Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter